Smooth Muscle Phenotype Switching in Blast Traumatic Brain Injury-Induced Cerebral Vasospasm

Translational Stroke Research

Volumn 5, Issue 3, 2014, Pages 385-393

  Hald, Eric S ^a   Alford, Patrick W ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Biomechanics; Blast traumatic brain injury; Cerebral vasospasm; Phenotype transformation; Subarachnoid hemorrhage; Vascular smooth muscle cells

Indexed keywords

ARTICLE; BLAST INJURY; BRAIN VASOSPASM; DISEASE COURSE; MECHANICAL STIMULATION; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; SUBARACHNOID HEMORRHAGE; TRAUMATIC BRAIN INJURY; TREATMENT PLANNING; ANIMAL; BRAIN INJURY; COMPLICATION; HUMAN; METABOLISM; PATHOLOGY; VASCULAR REMODELING; VASCULAR SMOOTH MUSCLE; VASOSPASM, INTRACRANIAL;

ANIMALS; BLAST INJURIES; BRAIN INJURIES; HUMANS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHENOTYPE; VASCULAR REMODELING; VASOSPASM, INTRACRANIAL;

EID: 84901250207     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-013-0300-3     Document Type: Article

References (112)

1. Faul MD, Wald MM, Xu L, Coronado VG. Traumatic brain injury in the United States: emergency department visits, hospitalizations, and deaths, 2002-2006. Atlanta: Centers for Disease Control and Prevention, National Center for Injury Prevention and Control 2010; 2010.
2. Armonda RA, Bell RS, Vo AH, Ling G, DeGraba TJ, Crandall B, et al. Wartime traumatic cerebral vasospasm: recent review of combat casualties. Neurosurgery. 2006;59(6): 1215-25. doi: 10. 1227/01. neu. 0000249190. 46033. 94. discussion 25.
3. Goldstein LE, Fisher AM, Tagge CA, Zhang XL, Velisek L, Sullivan JA, et al. Chronic traumatic encephalopathy in blast-exposed military veterans and a blast neurotrauma mouse model. Sci Transl Med. 2012;4(134): 134ra60. doi: 10. 1126/scitranslmed. 3003716.
4. Bhattacharjee Y. Shell shock revisited: solving the puzzle of blast trauma. Science. 2008;319: 406-8.
5. Ling G, Bandak F, Armonda R, Grant G, Ecklund J. Explosive blast neurotrauma. J Neurotrauma. 2009;26(6): 815-25. doi: 10. 1089/neu. 2007. 0484.
6. Borel CO, McKee A, Parra A, Haglund MM, Solan A, Prabhakar V, et al. Possible role for vascular cell proliferation in cerebral vasospasm after subarachnoid hemorrhage. Stroke. 2003;34(2): 427-33. doi: 10. 1161/01. str. 0000053848. 06436. ab. Editorial comment.
7. Zhang ZD, Macdonald RL. Contribution of the remodeling response to cerebral vasospasm. Neurol Res. 2006;28(7): 713-20. doi: 10. 1179/016164106X151990.
8. Humphrey JD, Baek S, Niklason LE. Biochemomechanics of cerebral vasospasm and its resolution: I. A new hypothesis and theoretical framework. Ann Biomed Eng. 2007;35(9): 1485-97. doi: 10. 1007/s10439-007-9321-y.
9. Alford PW, Dabiri BE, Goss JA, Hemphill MA, Brigham MD, Parker KK. Blast-induced phenotypic switching in cerebral vasospasm. Proc Natl Acad Sci U S A. 2011;108(31): 12705-10. doi: 10. 1073/pnas. 1105860108.
10. Courtney AC, Courtney MW. A thoracic mechanism of mild traumatic brain injury due to blast pressure waves. Med Hypotheses. 2009;72(1): 76-83. doi: 10. 1016/j. mehy. 2008. 08. 015.
11. Long JB, Bentley TL, Wessner KA, Cerone C, Sweeney S, Bauman RA. Blast overpressure in rats: recreating a battlefield injury in the laboratory. J Neurotrauma. 2009;26(6): 827-40. doi: 10. 1089/neu. 2008. 0748.
12. Bauman RA, Ling G, Tong L, Januszkiewicz A, Agoston D, Delanerolle N, et al. An introductory characterization of a combat-casualty-care relevant swine model of closed head injury resulting from exposure to explosive blast. J Neurotrauma. 2009;26(6): 841-60. doi: 10. 1089/neu. 2009-0898.
13. Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci. 2011;12(12): 723-38. doi: 10. 1038/nrn3114.
14. Geddes DM, Cargill RS 2nd, LaPlaca MC. Mechanical stretch to neurons results in a strain rate and magnitude-dependent increase in plasma membrane permeability. J Neurotrauma. 2003;20(10): 1039-49. doi: 10. 1089/089771503770195885.
15. Kilinc D, Gallo G, Barbee KA. Mechanically-induced membrane poration causes axonal beading and localized cytoskeletal damage. Exp Neurol. 2008;212(2): 422-30. doi: 10. 1016/j. expneurol. 2008. 04. 025.
16. Pettus EH, Christman CW, Giebel ML, Povlishock JT. Traumatically induced altered membrane permeability: its relationship to traumatically induced reactive axonal change. J Neurotrauma. 1994;11(5): 507-22.
17. Hemphill MA, Dabiri BE, Gabriele S, Kerscher L, Franck C, Goss JA, et al. A possible role for integrin signaling in diffuse axonal injury. PLoS One. 2011;6(7): e22899. doi: 10. 1371/journal. pone. 0022899.
18. Yeoh S, Bell ED, Monson KL. Distribution of blood-brain barrier disruption in primary blast injury. Ann Biomed Eng. 2013;41(10): 2206-14. doi: 10. 1007/s10439-013-0805-7.
19. Chen Y, Huang W, Constantini S. Blast shock wave mitigation using the hydraulic energy redirection and release technology. PLoS One. 2012;7(6): e39353. doi: 10. 1371/journal. pone. 0039353.
20. Kuehn R, Simard PF, Driscoll I, Keledjian K, Ivanova S, Tosun C, et al. Rodent model of direct cranial blast injury. J Neurotrauma. 2011;28(10): 2155-69. doi: 10. 1089/neu. 2010. 1532.
21. Garman RH, Jenkins LW, Switzer RC 3rd, Bauman RA, Tong LC, Swauger PV, et al. Blast exposure in rats with body shielding is characterized primarily by diffuse axonal injury. J Neurotrauma. 2011;28(6): 947-59. doi: 10. 1089/neu. 2010. 1540.
22. Readnower RD, Chavko M, Adeeb S, Conroy MD, Pauly JR, McCarron RM, et al. Increase in blood-brain barrier permeability, oxidative stress, and activated microglia in a rat model of blast-induced traumatic brain injury. J Neurosci Res. 2010;88(16): 3530-9. doi: 10. 1002/jnr. 22510.
23. Hue CD, Cao S, Haider SF, Vo KV, Effgen GB, Vogel E 3rd, et al. Blood-brain barrier dysfunction after primary blast injury in vitro. J Neurotrauma. 2013;30(19): 1652-63. doi: 10. 1089/neu. 2012. 2773.
24. Murakami K, Koide M, Dumont TM, Russell SR, Tranmer BI, Wellman GC. Subarachnoid hemorrhage induces gliosis and increased expression of the pro-inflammatory cytokine high mobility group box 1 protein. Transl Stroke Res. 2011;2(1): 72-9. doi: 10. 1007/s12975-010-0052-2.
25. Harrison P, Cramer EM. Platelet alpha-granules. Blood Rev. 1993;7(1): 52-62.
26. Keilin D, Hartree EF. Reaction of nitric oxide with haemoglobin and methaemoglobin. Nature. 1937;139: 548.
27. Gow J, Stamler J. Reactions between nitric oxide and haemoglobin under physiological conditions. Nature. 1998;391: 169-73.
28. Gladwin MT, Lancaster JR Jr, Freeman BA, Schechter AN. Nitric oxide's reactions with hemoglobin: a view through the SNO-storm. Nat Med. 2003;9(5): 496-500. doi: 10. 1038/nm0503-496.
29. Shimokawa H, Ito A, Fukumoto Y, Kadokami T, Nakaike R, Sakata M, et al. Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derived growth factor. J Clin Investig. 1996;97(3): 769-76. doi: 10. 1172/JCI118476.
30. Dietrich HH, Dacey RG Jr. Molecular keys to the problems of cerebral vasospasm. Neurosurgery. 2000;46(3): 517-30.
31. Dumont AS, Dumont RJ, Chow MM, Lin CL, Calisaneller T, Ley KF, et al. Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery. 2003;53(1): 123-33. discussion 33-5.
32. Grasso G. An overview of new pharmacological treatments for cerebrovascular dysfunction after experimental subarachnoid hemorrhage. Brain Res Brain Res Rev. 2004;44(1): 49-63.
33. Boron WF, Boulpaep EL. Medical physiology: a cellular and molecular approach. 1st ed. Philadelphia: W. B. Saunders; 2003.
34. Balabanov R, Goldman H, Murphy S, Pellizon G, Owen C, Rafols J, et al. Endothelial cell activation following moderate traumatic brain injury. Neurol Res. 2001;23(2-3): 175-82.
35. Clower BR, Yamamoto Y, Cain L, Haines DE, Smith RR. Endothelial injury following experimental subarachnoid hemorrhage in rats: effects on brain blood flow. Anat Rec. 1994;240(1): 104-14. doi: 10. 1002/ar. 1092400110.
36. Bohm F, Pernow J. The importance of endothelin-1 for vascular dysfunction in cardiovascular disease. Cardiovasc Res. 2007;76(1): 8-18. doi: 10. 1016/j. cardiores. 2007. 06. 004.
37. Zimmermann M, Seifert V. Endothelin and subarachnoid hemorrhage: an overview. Neurosurgery. 1998;43(4): 863-75. discussion 75-6.
38. Vatter H, Konczalla J, Seifert V. Endothelin related pathophysiology in cerebral vasospasm: what happens to the cerebral vessels? Acta Neurochir Suppl. 2011;110(Pt 1): 177-80. doi: 10. 1007/978-3-7091-0353-1_31.
39. Owens GK. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev. 1995;75(3): 487-517.
40. Iyemere VP, Proudfoot D, Weissberg PL, Shanahan CM. Vascular smooth muscle cell phenotypic plasticity and the regulation of vascular calcification. J Intern Med. 2006;260(3): 192-210. doi: 10. 1111/j. 1365-2796. 2006. 01692. x.
41. Alexander MR, Owens GK. Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. Annu Rev Plant Physiol Plant Mol Biol. 2012;74: 13-40. doi: 10. 1146/annurev-physiol-012110-142315.
42. Stegemann JP, Hong H, Nerem RM. Mechanical, biochemical, and extracellular matrix effects on vascular smooth muscle cell phenotype. J Appl Physiol. 2005;98(6): 2321-7. doi: 10. 1152/japplphysiol. 01114. 2004.
43. Chesler NC, Ku DN, Galis ZS. Transmural pressure induces matrix-degrading activity in porcine arteries ex vivo. Am J Physiol. 1999;277(5 Pt 2): H2002-9.
44. Zabramski JM. Vasospasm after subarachnoid hemorrhage. In: Bederson JB, editor. Subarachnoid hemorrhage: pathophysiology and management. Park Ridge: The American Association of Neurological Surgeons; 1997. p. 127-56.
45. Macdonald RL. Pathophysiology and molecular genetics of vasospasm. Acta Neurochir Supplement. 2001;77: 7-11.
46. Mayberg MR, Okada T, Bark DH. The significance of morphological changes in cerebral arteries after subarachnoid hemorrhage. J Neurosurg. 1990;72(4): 626-33. doi: 10. 3171/jns. 1990. 72. 4. 0626.
47. McGirt MJ, Lynch JR, Blessing R, Warner DS, Friedman AH, Laskowitz DT. Serum von Willebrand factor, matrix metalloproteinase-9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery. 2002;51(5): 1128-34. discussion 34-5.
48. Pluta RM. Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment. Pharmacol Ther. 2005;105(1): 23-56. doi: 10. 1016/j. pharmthera. 2004. 10. 002.
49. Zhang B, Fugleholm K, Day LB, Ye S, Weller RO, Day IN. Molecular pathogenesis of subarachnoid haemorrhage. Intern J Biochem Cell Biol. 2003;35(9): 1341-60.
50. Liu SQ, Fung YC. Zero-stress states of arteries. J Biomech Eng. 1988;110(1): 82-4.
51. Armentano R, Simon A, Levenson J, Chau NP, Megnien JL, Pichel R. Mechanical pressure versus intrinsic effects of hypertension on large arteries in humans. Hypertension. 1991;18(5): 657-64.
52. Intengan HD, Schiffrin EL. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension. 2001;38(3 Pt 2): 581-7.
53. Fung YC, Liu SQ. Changes of zero-stress state of rat pulmonary arteries in hypoxic hypertension. J Appl Physiol. 1991;70(6): 2455-70.
54. Fung YC, Liu SQ. Change of residual strains in arteries due to hypertrophy caused by aortic constriction. Circ Res. 1989;65(5): 1340-9.
55. Alford PW, Humphrey JD, Taber La. Growth and remodeling in a thick-walled artery model: effects of spatial variations in wall constituents. Biomech Model Mechanobiol. 2008;7(4): 245-62. doi: 10. 1007/s10237-007-0101-2.
56. Alford PW, Taber LA. Computational study of growth and remodelling in the aortic arch. Comput Method Biomech Biomed Engin. 2008;11(5): 525-38. doi: 10. 1080/10255840801930710.
57. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 2004;84(3): 767-801. doi: 10. 1152/physrev. 00041. 2003.
58. Kawai-Kowase K, Owens GK. Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells. Am J Physiol Cell Physiol. 2007;292(1): C59-69. doi: 10. 1152/ajpcell. 00394. 2006.
59. Chow N, Bell RD, Deane R, Streb JW, Chen J, Brooks A, et al. Serum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in Alzheimer's phenotype. Proc Natl Acad Sci U S A. 2007;104(3): 823-8. doi: 10. 1073/pnas. 0608251104.
60. Li S, Lao J, Chen BP, Li YS, Zhao Y, Chu J, et al. Genomic analysis of smooth muscle cells in 3-dimensional collagen matrix. FASEB J. 2003;17(1): 97-9. doi: 10. 1096/fj. 02-0256fje.
61. Schulze PC, de Keulenaer GW, Kassik KA, Takahashi T, Chen Z, Simon DI, et al. Biomechanically induced gene iex-1 inhibits vascular smooth muscle cell proliferation and neointima formation. Circ Res. 2003;93(12): 1210-7. doi: 10. 1161/01. RES. 0000103635. 38096. 2F.
62. Chapman GB, Durante W, Hellums JD, Schafer AI. Physiological cyclic stretch causes cell cycle arrest in cultured vascular smooth muscle cells. Am J Physiol Heart Circ Physiol. 2000;278(3): H748-54.
63. Kim BS, Nikolovski J, Bonadio J, Mooney DJ. Cyclic mechanical strain regulates the development of engineered smooth muscle tissue. Nat Biotechnol. 1999;17(10): 979-83. doi: 10. 1038/13671.
64. Williams B. Mechanical influences on vascular smooth muscle cell function. J Hypertens. 1998;16(12 Pt 2): 1921-9.
65. McDaniel DP, Shaw GA, Elliott JT, Bhadriraju K, Meuse C, Chung KH, et al. The stiffness of collagen fibrils influences vascular smooth muscle cell phenotype. Biophys J. 2007;92(5): 1759-69. doi: 10. 1529/biophysj. 106. 089003.
66. Sazonova OV, Lee KL, Isenberg BC, Rich CB, Nugent MA, Wong JY. Cell-cell interactions mediate the response of vascular smooth muscle cells to substrate stiffness. Biophys J. 2011;101(3): 622-30. doi: 10. 1016/j. bpj. 2011. 06. 051.
67. Alford PW, Nesmith AP, Seywerd JN, Grosberg A, Parker KK. Vascular smooth muscle contractility depends on cell shape. Integr Biol (Camb). 2011;3(11): 1063-70. doi: 10. 1039/c1ib00061f.
68. Peyton SR, Putnam AJ. Extracellular matrix rigidity governs smooth muscle cell motility in a biphasic fashion. J Cell Physiol. 2005;204(1): 198-209. doi: 10. 1002/jcp. 20274.
69. Masel BE, Bell RS, Brossart S, Grill RJ, Hayes RL, Levin HS, et al. Galveston brain injury conference 2010: clinical and experimental aspects of blast injury. J Neurotrauma. 2012;29(12): 2143-71. doi: 10. 1089/neu. 2011. 2258.
70. DeWitt DS, Prough DS. Blast-induced brain injury and posttraumatic hypotension and hypoxemia. J Neurotrauma. 2009;26(6): 877-87. doi: 10. 1089/neu. 2007. 0439.
71. Liu G, Wang H, Ou D, Huang H, Liao D. Endothelin-1, an important mitogen of smooth muscle cells of spontaneously hypertensive rats. Chin Med J. 2002;115(5): 750-2.
72. Chambers RC, Leoni P, Kaminski N, Laurent GJ, Heller RA. Global expression profiling of fibroblast responses to transforming growth factor-beta1 reveals the induction of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotypic switching. Am J Pathol. 2003;162(2): 533-46.
73. Jain MK, Fujita KP, Hsieh CM, Endege WO, Sibinga NE, Yet SF, et al. Molecular cloning and characterization of SmLIM, a developmentally regulated LIM protein preferentially expressed in aortic smooth muscle cells. J Biol Chem. 1996;271(17): 10194-9.
74. Lin DW, Chang IC, Tseng A, Wu ML, Chen CH, Patenaude CA, et al. Transforming growth factor beta up-regulates cysteine-rich protein 2 in vascular smooth muscle cells via activating transcription factor 2. J Biol Chem. 2008;283(22): 15003-14. doi: 10. 1074/jbc. M801621200.
75. Wu YC, Cui L, Li G, Yin S, Gao YJ, Cao YL. [PDGF-BB initiates vascular smooth muscle-like phenotype differentiation of human bone marrow mesenchymal stem cells in vitro]. Zhonghua zheng xing wai ke za zhi Zhonghua zhengxing waike zazhi (Chin J Plast Surg). 2007;23(4): 335-9.
76. Holycross BJ, Blank RS, Thompson MM, Peach MJ, Owens GK. Platelet-derived growth factor-BB-induced suppression of smooth muscle cell differentiation. Circ Res. 1992;71(6): 1525-32.
77. Li X, van Putten V, Zarinetchi F, Nicks ME, Thaler S, Heasley LE, et al. Suppression of smooth-muscle alpha-actin expression by platelet-derived growth factor in vascular smooth-muscle cells involves Ras and cytosolic phospholipase A2. Biochem J. 1997;327(Pt 3): 709-16.
78. Lehti K, Rose NF, Valavaara S, Weiss SJ, Keski-Oja J. MT1-MMP promotes vascular smooth muscle dedifferentiation through LRP1 processing. J Cell Sci. 2009;122(Pt 1): 126-35. doi: 10. 1242/jcs. 035279.
79. Song JN, Yan WT, An JY, Hao GS, Guo XY, Zhang M, et al. Potential contribution of SOCC to cerebral vasospasm after experimental subarachnoid hemorrhage in rats. Brain Res. 2013;1517: 93-103. doi: 10. 1016/j. brainres. 2013. 01. 004.
80. Berra-Romani R, Mazzocco-Spezzia A, Pulina MV, Golovina VA. Ca2+ handling is altered when arterial myocytes progress from a contractile to a proliferative phenotype in culture. Am J Physiol Cell Physiol. 2008;295(3): C779-90. doi: 10. 1152/ajpcell. 00173. 2008.
81. House SJ, Potier M, Bisaillon J, Singer HA, Trebak M. The non-excitable smooth muscle: calcium signaling and phenotypic switching during vascular disease. Pflugers Archiv: Eur J Physiol. 2008;456(5): 769-85. doi: 10. 1007/s00424-008-0491-8.
82. Hubbell MC, Semotiuk AJ, Thorpe RB, Adeoye OO, Butler SM, Williams JM, et al. Chronic hypoxia and VEGF differentially modulate abundance and organization of myosin heavy chain isoforms in fetal and adult ovine arteries. Am J Physiol Cell Physiol. 2012;303(10): C1090-103. doi: 10. 1152/ajpcell. 00408. 2011.
83. Adeoye OO, Butler SM, Hubbell MC, Semotiuk A, Williams JM, Pearce WJ. Contribution of increased VEGF receptors to hypoxic changes in fetal ovine carotid artery contractile proteins. Am J Physiol Cell Physiol. 2013;304(7): C656-65. doi: 10. 1152/ajpcell. 00110. 2012.
84. MacDonald RL, Weir, B. Cerebral Vasospasm. Academic Press; 2001.
85. Sugawara T, Ayer R, Jadhav V, Chen W, Tsubokawa T, Zhang JH. Mechanisms of statin treatment in cerebral vasospasm. Acta Neurochir Suppl. 2011;110(Pt 2): 9-11. doi: 10. 1007/978-3-7091-0356-2_2.
86. Satoh S, Takayasu M, Kawasaki K, Ikegaki I, Hitomi A, Yano K, et al. Antivasospastic effects of hydroxyfasudil, a Rho-kinase inhibitor, after subarachnoid hemorrhage. J Pharmacol Sci. 2012;118(1): 92-8.
87. Naraoka M, Munakata A, Matsuda N, Shimamura N, Ohkuma H. Suppression of the Rho/Rho-kinase pathway and prevention of cerebral vasospasm by combination treatment with statin and fasudil after subarachnoid hemorrhage in rabbit. Transl Stroke Res. 2013;4(3): 368-74. doi: 10. 1007/s12975-012-0247-9.
88. Amenta F, Lanari A, Mignini F, Silvestrelli G, Traini E, Tomassoni D. Nicardipine use in cerebrovascular disease: a review of controlled clinical studies. J Neurol Sci. 2009;283(1-2): 219-23. doi: 10. 1016/j. jns. 2009. 02. 335.
89. Inzitari D, Poggesi A. Calcium channel blockers and stroke. Aging Clin Exp Res. 2005;17(4 Suppl): 16-30.
90. Mesis RG, Wang H, Lombard FW, Yates R, Vitek MP, Borel CO, et al. Dissociation between vasospasm and functional improvement in a murine model of subarachnoid hemorrhage. Neurosurg Focus. 2006;21(3): E4.
91. Zhang Z, Mondello S, Kobeissy F, Rubenstein R, Streeter J, Hayes RL, et al. Protein biomarkers for traumatic and ischemic brain injury: from bench to bedside. Transl Stroke Res. 2011;2: 455-62.
92. North SH, Shriver-Lake LC, Taitt CR, Ligler FS. Rapid analytical methods for on-site triage for traumatic brain injury. Annu Rev Anal Chem (Palo Alto, CA). 2012;5: 35-56. doi: 10. 1146/annurev-anchem-062011-143105.
93. Ogawa T, Hanggi D, Wu Y, Michiue H, Tomizawa K, Ono S, et al. Protein therapy using heme-oxygenase-1 fused to a polyarginine transduction domain attenuates cerebral vasospasm after experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2011;31(11): 2231-42. doi: 10. 1038/jcbfm. 2011. 87.
94. Ram Z, Sadeh M, Shacked I, Sahar A, Hadani M. Magnesium sulfate reverses experimental delayed cerebral vasospasm after subarachnoid hemorrhage in rats. Stroke. 1991;22(7): 922-7.
95. Huang B, Khatibi NH, Tong L, Yan P, Xie P, Zhang JH. Magnesium sulfate treatment improves outcome in patients with subarachnoid hemorrhage: a meta-analysis study. Transl Stroke Res. 2010;1(2): 108-12. doi: 10. 1007/s12975-010-0022-8.
96. MacDonald RL, Kakarieka A, Mayer SA, Pasqualin A, Ruefenacht D, Schmiedek P, et al. Prevention of cerebral vasospasm after aneurysmal subarachnoid hemorrhage with clazosentan, an endothelin receptor antagonist. Neurosurgery. 2006;59(2): 453.
97. Macdonald RL. Clazosentan: an endothelin receptor antagonist for treatment of vasospasm after subarachnoid hemorrhage. Expert Opin Investig Drug. 2008;17(11): 1761-7. doi: 10. 1517/13543784. 17. 11. 1761.
98. Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, et al. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol. 2011;10(7): 618-25. doi: 10. 1016/S1474-4422(11)70108-9.
99. Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, et al. Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling. Stroke. 2012;43(6): 1463-9. doi: 10. 1161/STROKEAHA. 111. 648980.
100. Yamaguchi-Okada M, Nishizawa S, Mizutani A, Namba H. Multifaceted effects of selective inhibitor of phosphodiesterase III, cilostazol, for cerebral vasospasm after subarachnoid hemorrhage in a dog model. Cerebrovasc Dis. 2009;28(2): 135-42. doi: 10. 1159/000223439.
101. Ostrowski RP, Zhang JH. Hyperbaric oxygen for cerebral vasospasm and brain injury following subarachnoid hemorrhage. Transl Stroke Res. 2011;2(3): 316-27. doi: 10. 1007/s12975-011-0069-1.
102. Soejima Y, Hu Q, Krafft PR, Fujii M, Tang J, Zhang JH. Hyperbaric oxygen preconditioning attenuates hyperglycemia-enhanced hemorrhagic transformation by inhibiting matrix metalloproteinases in focal cerebral ischemia in rats. Exp Neurol. 2013;247: 737-43. doi: 10. 1016/j. expneurol. 2013. 03. 019.
103. Monson KL, Matsumoto MM, Young WL, Manley GT, Hashimoto T. Abrupt increase in rat carotid blood flow induces rapid alteration of artery mechanical properties. J Mech Behav Biomed Mater. 2011;4(1): 9-15. doi: 10. 1016/j. jmbbm. 2010. 08. 003.
104. Jackson ZS, Gotlieb AI, Langille BL. Wall tissue remodeling regulates longitudinal tension in arteries. Circ Res. 2002;90(8): 918-25.
105. Etminan N, Vergouwen MD, Ilodigwe D, Macdonald RL. Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Cereb Blood Flow Metab. 2011;31(6): 1443-51. doi: 10. 1038/jcbfm. 2011. 7.
106. Dreier JP, Major S, Manning A, Woitzik J, Drenckhahn C, Steinbrink J, et al. Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage. Brain: J Neurol. 2009;132(Pt 7): 1866-81. doi: 10. 1093/brain/awp102.
107. Vergouwen MD, Etminan N, Ilodigwe D, Macdonald RL. Lower incidence of cerebral infarction correlates with improved functional outcome after aneurysmal subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2011;31(7): 1545-53. doi: 10. 1038/jcbfm. 2011. 56.
108. Vergouwen MD, Ilodigwe D, Macdonald RL. Cerebral infarction after subarachnoid hemorrhage contributes to poor outcome by vasospasm-dependent and -independent effects. Stroke. 2011;42(4): 924-9. doi: 10. 1161/STROKEAHA. 110. 597914.
109. Cernak I, Savic J, Malicevic Z, Zunic G, Djurdjevic D, Prokic V. The pathogenesis of pulmonary blast injury: our point of view. Chinese J Traumatol. 1996;12: 28-31.
110. Cernak I, Malicevik Z, Prokic V, Zunic G, Djurdjevic D, Ilic S, et al. Indirect neurotrauma caused by pulmonary blast injury: development and prognosis. Int Rev Armed Forces Med Serv. 1997;52: 114-20.
111. Cernak I, Wang Z, Jiang J, Bian X, Savic J. Ultrastructural and functional characteristics of blast injury-induced neurotrauma. J Trauma. 2001;50(4): 695-706.
112. Cernak I, Ignjatovic D, Andelic G, Savic J. Metabolic changes as part of the general response of the body to the effect of blast waves. Vojnosanitetski Pregled Mil (Med Pharm Rev). 1991;48(6): 515-22.